机译:进化保守蛋白ERH控制CENP-E mRNA剪接,对于KRAS突变癌细胞的生存是必需的
Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892,Graduate Institute of Clinical Medicine, National Taiwan University, Taipei 100, Taiwan,Far-Eastern Memorial Hospital, Taipei 220, Taiwan;
Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Department of Internal Medicine,National Taiwan University Hospital and College of Medicine, Taipei 100, Taiwan;
Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Proteomics Core Facility, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892;
Confocal Microscopy Core Facility, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Confocal Microscopy Core Facility, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Proteomics Core Facility, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892;
Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Department of Medicine and Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX 77030;
Department of Genetics, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115;
Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Department of Internal Medicine,National Taiwan University Hospital and College of Medicine, Taipei 100, Taiwan;
Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
机译:Rbfox蛋白通过进化保守的RNA桥调控可变的mRNA剪接
机译:异戊二烯基琥珀酸羧甲基转移酶是突变蛋白克拉斯对TAZ蛋白水平和癌细胞自我更新的影响所必需的
机译:剪接的mRNA的质量控制需要穿梭SR蛋白Gbp2和Hrb1
机译:L-抗坏血酸可以消除突变克拉斯在人结肠癌细胞中介导的X基因依赖性的辛酸抗性
机译:HSV-1调节蛋白ICP27与关键宿主细胞蛋白相互作用,以介导抑制前mRNA剪接和无内含子病毒mRNA的输出。
机译:PNAS Plus:进化保守的蛋白ERH控制CENP-E mRNA的剪接对于KRAS突变癌细胞的生存是必需的
机译:异戊二烯基琥珀酸羧甲基转移酶是突变蛋白克拉斯对TAZ蛋白水平和癌细胞自我更新的影响所必需的
机译:使用进化精制疟疾蛋白靶向乳腺癌细胞和干细胞上常见但复杂的蛋白多糖。